SAN FRANCISCO A recent study has shown clinical improvement of Parkinson's disease symptoms after long-term infusion of a neurorestorative molecule, pumped directly to the center of the brain. The study will be presented at the American Academy of Neurology 56th Annual Meeting in San Francisco, Calif., April 24 May 1, 2004.

The cause of Parkinson's disease (PD) is a dopamine deficiency in the brain. Dopamine is a neurotransmitter, a chemical messenger in the nervous system. In PD the neural cells that produce dopamine deteriorate, and the normal rate of dopamine production decreases.

In this study, researchers examined the brain's ability to increase dopamine production by infusing human brain derived molecules called glial cell line-derived neurotrophic factor (GDNF). Five patients with advanced PD underwent insertion of a small tube into their brains, through which the GDNF was infused over the course of two years.

Using the Unified Parkinson's Disease Rating Scale (UPDRS), which measures many facets of PD progression, study participants were tested pre- and post-operatively at six-month intervals for two years. They were also examined using PET imaging to determine the uptake (level) of 18F-dopa, a dopamine generator.

"We were very encouraged by our results," notes study author Gary Hotton, BSc, MBBS, from Professor D. Brooks' research group at Imperial College and Hammersmith Hospital, London. "The patients experienced a 41 percent improvement in total UPDRS and a 44 percent improvement in the UPDRS motor function section."

This study shows that chronic infusion of GDNF results in a clinical improvement in PD, sustained for at least two years. It also showed a significant increase in 18F-dopa uptake localized to the tip of the infusion tube. Further study may be warranted to determine continued effects.

'"/>

Contact: Kathy Stone
kstone@aan.com
651-695-2763
American Academy of Neurology
27-Apr-2004

Page: 1
Related medicine news :

1. Molecule important in cell construction also critical in learning and memory
2. Molecule predicts colon cancer patient survival
3. Molecule expressed early in pregnancy may help patients tolerate transplants
4. Molecules inhibit HIV protease, could lead to new line of attack against AIDS
5. UK Researchers Receive $1.14 Million NIH Grant To Study A Molecule That May Have A Role In Diseases Involving Oxidative Cell Death
6. Immunexs TRAIL Molecule Shows Potential As Anti-Tumor Agent
7. Status syndrome: How your social standing directly affects your health and life expectancy
8. Occupation directly impacts a womans retirement, study says
9. Study finds childhood health is directly related to social class
10. Some brain cells change channels to fine-tune the message
11. First mouse model for multiple system atrophy points to new treatment targets for brain diseases